Tenomodulin (TeM) is a type II transmembrane glycoprotein containing a C-terminal anti-angiogenic domain and is predominantly expressed in tendons and ligaments. Here we report that TeM expression is closely associated with the appearance of tenocytes during chick development and is positively regulated by Scleraxis (Scx). At stage 23, when Scx expression in the syndetome has extended to the tail region, TeM was detectable in the anterior eight somites. At stage 25, TeM and Scx were both detectable in the regions adjacent to the myotome. Double positive domains for these genes were flanked by a dorsal TeM single positive and a ventral Scx single positive domain. At stage 28, the expression profile of TeM in the axial tendons displayed more distinct morphological features at different levels of the vertebrae. At stage 32 and later, Scx and TeM showed similar expression profiles in developing tendons. Retroviral expression of Scx resulted in the significant upregulation of TeM in cultured tenocytes, but not in chondrocytes. In addition, the misexpression of RCAS-cScx by electroporation into the hindlimb could not induce the generation of additional tendons, but did result in the upregulation of TeM expression in the tendons at stage 33 and later. These findings suggest that TeM is a late marker of tendon formation and that Scx positively regulates TeM expression in a tendon cell lineage-dependent manner.
Introduction
The tendons are tough bands of dense fibrous connective tissue that connect skeletal muscle to the skeletal elements. Their high tensile strength principally depends on dense regular bundles of type I collagen fibers that are produced by elongated fibroblasts known as tenocytes. Tenocytes are aligned longitudinally between the collagen fibers along the tendon axis (Benjamin and Ralphs, 1997; Kannus, 2000) and have the potential to communicate with one another via specific cellular processes and gap junctions that could form the basis of a load sensing system, thereby allowing the tenocytes to modulate their extracellular matrices (Canty and Kadler, 2005; McNeilly et al., 1996) .
During the early stages of musculoskeletal development, tendon progenitors proliferate and migrate to form a tendon primordium. This tendon primordium then segregates into individual anatomically distinct tendons, which interact with developing muscle masses and skeletal elements and connect them to each other (Kardon, 1998) . In the developing tendons, tenocytes align in parallel arrays along the tendon axis and deposit large amounts of extracellular matrices including collagens, elastin and small leucin-rich proteoglycans (Kannus, 2000) . Collagen fibers, mainly consisting of type I collagen, show a highly organized parallel structure around the tenocytes. A recent 3-D serial section reconstruction study has revealed that the architecture characterized by parallel alignment of collagen fibers in tendons is achieved through the fibripositor formation of tenocytes during embryonic development (Canty and Kadler, 2005; Canty et al., 2004) .
At present, few genes have been reported as general tendon markers that can be used to delineate the sequence of tendon development (Edom-Vovard and Duprez, 2004) . Despite their unique architecture, most structural components of tendons are also expressed in other connective tissues. Among these, tenascin (TN) has been employed as a tendon marker, although it is also expressed in cartilage and nerve (Kardon, 1998; Ros et al., 1995; Tucker et al., 1994) . Recently, Scx has been reported as a marker of the progenitor populations of tendons and tenocytes (Cserjesi et al., 1995; Schweitzer et al., 2001 ). Based Developmental Biology 298 (2006) 234 -247 www.elsevier.com/locate/ydbio on the expression pattern of Scx, the syndetome containing the tendon progenitor population was defined as the fourth compartment of the somites, in addition to myotome, sclerotome and dermomyotome (Brent et al., 2003) . Ectopic application of FGF8 or FGF4 has been shown to induce the expansion of Scx expression in the sclerotomal cells near the myotome (Brent et al., 2003) . The classical ERK MAP kinase pathway plays an important role in the regulation of Scx expression by FGF signaling (Smith et al., 2005) . The restriction of Scx expression in the syndetome is regulated by the Ets transcription factors Pea3 and Erm (Brent and Tabin, 2004) . In limb tendons, FGF4 also positively regulates Scx and TN expression (Edom-Vovard et al., 2002) . In contrast, Shh and Pax-1 inhibit syndetome formation (Brent et al., 2003) . Compared with the upstream regulation of Scx expression, little is known about the downstream events that are closely associated with tenocyte differentiation. Moreover, to distinguish tenocytes from tendon progenitors during tendon development, an additional tendon marker that can selectively identify a differentiated population of tendon fibroblasts is required.
TeM is a type II transmembrane protein that is specifically expressed in dense connective tissues including tendons, ligaments, the epimysium of skeletal muscle, the cornea and the sclera (Brandau et al., 2001; Oshima et al., 2003; Pisani et al., 2004; Shukunami et al., 2001; Yamana et al., 2001 ). Mice lacking TeM display a severe decrease in tenocyte proliferation in newborn tendons and a disrupted adult collagen fibril structure (Docheva et al., 2005) . The soluble form of TeM, containing the C-terminal ChM-I like domain, inhibits the proliferation, migration and tube formation of vascular endothelial cells and also blocks the growth of malignant melanoma by inhibiting angiogenesis (Oshima et al., 2004; Shukunami et al., 2005) . Thus, TeM may prove to be a promising phenotypic marker of the later events during tendon development.
In our present study, the temporal and spatial expression profile of TeM during chick development was determined and compared with the expression domains of Scx and MyoD. Scx expression was found to precede TeM expression at the early stages of development in the musculoskeletal system. At stage 23, Scx expression in the syndetome extended to the tail region, whereas TeM was only detectable in the anterior eight somites. At stage 28, a region-specific expression profile of TeM was observed along the craniocaudal axis, depending on the levels of the vertebrae. At stage 32 and later, either cord-or sheet-like expression domains of TeM and Scx were observed in developing tendons. We also detected the expression of TeM in tenocytes isolated from leg tendons at stage 41. Using an in vitro culture system for tenocytes, we found that the retroviral expression of Scx results in the upregulation of TeM in tenocytes. This upregulation was not observed in cultured chondrocytes that were overexpressing Scx. Consistent with these results, in ovo electroporation of RCAS-Scx into hindlimb did not induced tendon expansion nor the production of additional tendons, but resulted in the upregulation of TeM in the tendons at stage 33 and later. These data clearly suggest that TeM is a good phenotypic marker for tenocytes, and that Scx positively regulates the expression of TeM in a tendon lineage-dependent manner.
Materials and methods

Cloning of chick TeM
Chick EST cDNA clones (BM491558 and BM487464) showing homology with human TeM were identified in the EST database of the National Center for Biotechnology Information (National Institutes of Health). A cDNA fragment of 551 bp was amplified from the cDNA prepared from the leg tendons of chick embryos at stage 43 by reverse transcription PCR. The following primers were designed to amplify the partial cDNA fragment, based on the nucleotide sequences from the EST clones: forward (5′-CGAGCGCTCGTCCTCGCGCA-CAGG-3′) and reverse (5′-GGAACTCCTTGTTCTGAATGG-3′). For the isolation of chick TeM cDNA clones, encompassing the entire coding region, a λgt11 cDNA library constructed from 10 day whole chicken embryos (Clontech) was employed. The inserts isolated from the phage clones were then subcloned into the EcoRI site of pBluescript SK (+) (Stratagene). Both cDNA strands were sequenced using standard sequence primers for this vector and gene-specific primers with a BigDye terminator v1.1 Cycle Sequencing Kit and an ABI 310 Genetic Analyzer (Applied Biosystems). The obtained sequences were compiled and analyzed by Macvector (Accelrys Software Inc.).
In situ hybridization
Chick embryos at different stages of development were obtained by incubation of fertilized white leghorn eggs at 38°C and staged according to the method described by Hamburger and Hamilton (Hamburger and Hamilton, 1992) . In some embryos, india ink was injected into the vitelline vein to visualize blood vessels. The antisense and sense RNA probes for each gene under analysis were transcribed from expression plasmids with a digoxygenin (DIG) RNA labeling kit (Roche). For whole mount in situ hybridization, chick embryos were fixed in 4% paraformaldehyde (PFA), resolved in phosphate-buffered saline (PBS) overnight and gradually transferred into methanol by exchange of the PFA against increasing concentrations of methanol/PBS. After rehydration from the methanol, the embryos were hybridized with DIG-labeled antisense RNA probes, and/or DIGlabeled and fluorescein labeled antisense RNA probes. Following hybridization at 65°C overnight, the DIG-labeled molecules were detected using NBT/BCIP (Roche) as the substrate for the anti-DIG antibody-coupled alkaline phosphatase. After treatment with 4% PFA for 3 h and extensive washes with PBS, the alkaline phosphatase-coupled anti-FITC-antibody was applied in the same way, and the staining reaction was performed with INT/BCIP (Roche). Some embryos were embedded in OCT compound (Sakura) following whole mount in situ hybridization from which 20-30 μm sections were obtained. Appropriate control experiments were performed to exclude false-positive staining due to the endogenous alkaline phosphatase activity.
For in situ hybridization analysis of frozen sections, chick embryos were infiltrated with 18% sucrose/PBS at 4°C, followed by embedding in OCT compound and storage at − 80°C. For histological staining and in situ hybridization on paraffin sections from the same specimen, chick embryos were fixed in 4% PFA overnight, dehydrated in a graded series of ethanol and embedded in paraffin. Sections were then cut at a 6-10 μm thickness and mounted onto microscope slides for processing. For RNA probes, the cDNAs for TeM, ChM-I and MyoD were amplified by RT-PCR based on their published sequences in GenBank (NM206985, NM204810 and L34006, respectively). The Scx RNA probe was generated from its entire coding sequence in GenBank (AF505881), and from pcScx3′ UTR, which was a generous gift from Dr. Tabin. Type I collagen alpha 2 (Col1a2) and type II collagen alpha 1 (Col2a1) constructs were generously provided by Dr. BR. Olsen and used as templates for the generation of their respective RNA probes.
Immunohistochemistry
Following in situ hybridization, embryo sections were incubated with primary antibody at 4°C overnight, washed several times in PBS and reincubated with biotinylated horse anti-mouse secondary antibody (Vector Laboratories Inc.) for 30 min. Myosin heavy chain was detected with MF20 (diluted 1:5000; Developmental Studies Hybridoma Bank). Type II collagen was detected with Mouse anti-collagen Type II (diluted 1:200; RDI). Endogenous peroxidase activity was inactivated by incubation in 0.3% H 2 O 2 / PBS for 30 min, following the addition of secondary antibody. Sections were washed and incubated with ABComplex, and immunoreactivity was detected using the substrate kit for peroxidase of DAB or Nova RED (Vector Laboratories Inc.).
Histological staining
For azan staining, deparaffinized and hydrated sections were immersed in an azocarmine G solution for 30 min at 56-60°C, rinsed with an aniline alcohol solution and 1% acetic acid in ethanol, soaked in 5.0% phosphotungstic acid aqueous solution for 60 min at room temperature and dipped in aniline blueorange G solution for 30 min at room temperature.
Cell culture
Following trypsin and collagenase digestion, tenocytes were isolated from leg tendons of chick embryos at stages 41 or 43 and from distal tibiotarsal cartilage chick embryos at stage 41, respectively. Isolated tenocytes and chondrocytes were grown in αMEM medium containing 10% FBS and DME/ F12 medium containing 10% FBS, respectively, in a humidified atmosphere of 5% CO 2 in air.
Western blot analysis
Samples were electrophoresed on 12.5% SDS-polyacrylamide gels and transferred to Immobilon-P membranes (Millipore). After preincubation with blocking buffer (5% nonfat milk, 0.1% Tween 20 and 0.1% NaN 3 in PBS), the membranes were incubated with anti-FLAG monoclonal antibody M2 (SigmaAldrich), followed by horseradish peroxidase (HRP)-conjugated anti-rabbit IgG antibody and HRP-conjugated anti-mouse IgG antibody (Amersham Pharmacia Biotech), respectively. Peroxidase activity was detected and visualized using the enhanced chemiluminescence (ECL) plus system (Amersham Pharmacia Biotech), according to the manufacturer's instructions.
Northern blot analysis
Total RNA was prepared from cultured tendon fibroblasts, chondrocytes and from tendons isolated at HH stage 41 by a single step method. Total RNA (15 μg) was denatured with 6% formaldehyde, fractionated by 1% agarose gel electrophoresis and transferred onto Nytran membranes with Turboblotter (Schleicher and Schuell). Hybridization was performed overnight at 42°C with an appropriate cDNA probe labeled with [α- 32 P]dCTP from Amersham Biosciences in a solution containing 50% formamide, 6× SSPE, 0.1% bovine serum albumin, 0.1% Ficoll 400, 0.1% polyvinylpyrrolidone, 0.5% SDS and 100 μg/ml denatured salmon sperm DNA.
Plasmid construction
The coding region of chick Scx was amplified by PCR with the following primers: forward (5′-GCTCGCCATGTCCTTCGCCATGC-3′) and reverse (5′-TTCCCCGGGAGCGCCTAGCTCC-3′). The amplified products were subcloned into the p3xFLAG-CMV TM -10 expression vector to generate Flagtagged Scx. Flag-tagged Scx or untagged Scx inserts were then ligated to a pSLAX vector and subcloned into an RCASBP(A) retrovirus vector. The coding region of EGFP was subcloned into RCASBP(A) or RCASBP(B) retrovirus vector. The coding region of chick Myogenin was amplified by PCR with the following primers: forward (5′-CCATCGATAGCCGTGCACAGTCCTCCC-3′) and reverse (5′-CCATCGATCCAGCTCAGTTTTGGACCCG-3′). The amplified products were subcloned into the Cla-1 site of RCASBP(A) retrovirus vector. RCASA-mPax1 is a generous gift from Dr. K. Imai (Rodrigo et al., 2003) . Chicken embryonic fibroblasts (CEF) were transfected with these retrovirus constructs using FuGENE6 (Roche), and the transfected cells were then propagated. After two passages, the medium was replaced with fresh MEM supplemented with 1% FCS. After 24 h, the medium was harvested and concentrated by Centri-Sep (Applied Biosystems). Concentrated retroviral preparations were then used for the transfection of tenocytes and chondrocytes.
In ovo electroporation
Fertilized eggs were purchased from the Takeuchi poultry farm and incubated until the chick embryos reached Hamburger-Hamilton stages 16-17. A small window was opened for access and PBS was poured over the embryo to obtain an appropriate level of resistance (<0.5 Ω). A CUY-21 electroporator (Gene System) was used according to a previously reported method (Kida et al., 2004; Takeuchi et al., 1999) . Briefly, two platinum electrodes were used as an anode and a cathode. The anode was inserted beneath the embryonic endoderm and the cathode was placed on the ectoderm surface of the right hindlimb bud. A DNA solution (5 μg/μl) was added to the pCX-EGFP vector (5 μg/μl) at a 2:1 ratio and then injected by a sharp glass pipette in the lateral plate mesoderm under the right hindlimb bud. Electric pulses were then applied (9 V, 30 ms pulse-on, 70 ms pulse-off, three times) during the injection of the DNA.
Results
Cloning and sequence analysis of the chick TeM cDNA
TeM was cloned as a related gene of ChM-I, which was previously purified from bovine epiphyseal cartilage based on its growth stimulatory activity in chondrocytes (Hiraki et al., 1991) , and later identified as a vascular endothelial cell growth inhibitor (Brandau et al., 2001; Hiraki et al., 1997; Shukunami et al., 2001; Yamana et al., 2001) . TeM is a type II transmembrane protein with an anti-angiogenic domain at its Cterminus (Oshima et al., 2003 (Oshima et al., , 2004 . To study the role of TeM in the chicken embryo, we isolated the chicken homolog of mouse TeM and found that it contains an open reading frame of 957 nucleotides encoding 319 amino acids (Fig. 1A) . A KyteDoolittle hydrophilicity plot further suggested that chick TeM is also a type II transmembrane protein with a short cytoplasmic tail, followed by a hydrophobic transmembrane region with its C-terminus expressed on the exterior cell surface (Fig. 1B) . Two possible N-glycosylation sites in the BRICHOS domain were found at positions 95 and 181, both of which are conserved in mammals ( Fig. 1A ) (Sanchez-Pulido et al., 2002) . In addition, the chicken sequence has 62% overall identity with that of mouse or human. However, the ChM-I like domain from Phe 257 to Val 319 is a highly conserved moiety, which includes eight Cys residues, across the different species. Within this domain, the amino acid sequence is identical between mouse, rat, human and horse, and the homology was 87% between chick and mammals. The lowest level of similarity among the mammalian TeM proteins was observed from Ala 198 to Lys 234 , between the BRICHOS domain and the ChM-I like domain.
The genomic sequence of the chick TeM gene is available from the chicken Ensemble project. Chick TeM has been localized to chromosome 4. The sizes and boundaries of the exons and introns have been analyzed. As shown in Fig. 1C , the chick TeM gene spans approximately 7.76 kb and consists of seven exons, which all follow the AG-GT splicing consensus (not shown). Exon1 and exon2 encode the cytoplasmic Nterminal region and the transmembrane region, respectively. The extracellular region of the protein is encoded from exon2 to exon7. Exon7 contains the complete C-terminal anti-angiogenic domain, incorporating the eight Cys residues.
Induction of TeM is associated with the formation of tendon primodia during chick development
Scx is a marker of the syndetome, a sclerotomal subdomain containing a tendon progenitor population (Brent et al., 2003) . (Brandau et al., 2001; Shukunami et al., 2001; Yamana et al., 2001) , human (Shukunami et al., 2001 ) and horse TeM. The chicken sequence shares 62% homology with the previously cloned mouse, rat and human orthologs and 63% overall identity with horse. The conserved amino acid residues are shaded and gaps were introduced for optimal alignment. The putative transmembrane domains are underlined and conserved cysteine residues are indicated in bold. The potential N-linked glycosylation sites are denoted by asterisks. GenBank accession numbers for the aligned sequences are as follows: chick TeM, AY156693; mouse TeM, AF219993; rat TeM, NM02290; human TeM, AF234259; horse TeM, AB059407. (B) Kyte-Doolittle hydrophilicity plot of chick TeM. (C) The chick TeM gene has seven exons and spans 7.76 kb. Cytoplasmic portion and transmembrane domain are encoded by the first two exons. The extracellular domain is encoded by exon2-7.
Scx expressing cells are present at the anterior and posterior somitic borders along the cranio-caudal axis at stage 23 ( Fig.  2A) . In contrast, TeM expression is detectable only in the anterior eight somites at stage 23 (Fig. 2B ). In the cranial four somites, the faint expression of TeM was evident, but higher expression levels of TeM were visible in the posterior border of the fifth somite and in the anterior border of the sixth somite, followed by weaker signals in the seventh and eighth somite (Fig. 2B) . In the developing forelimb and hindlimb at stage 23, Scx can be detected in the proximomedial domains ( Fig. 2A) , whereas TeM was found to be diffusely expressed in the posterior region (Fig. 2B) .
The cranial four somites contribute to the formation of occipital bone and the remaining somites give rise to the vertebrae (Christ et al., 2000) . The chick vertebral system comprises 14 cervical vertebrae (C1-C14), 7 thoracic vertebrae (T1-T7), 4 lumber vertebrae, 9 sacral vertebrae (L1-L13) and ∼ 13 coccyges. At stage 28, more divergent expression patterns for TeM and Scx were observed, probably reflecting the regionspecific development of muscles and skeletal elements along the developing vertebral column (Figs. 2C-E). At the upper region of the cervical vertebrae, the fusion of Scx and TeM expressing domains in the anterior and posterior borders of somites could be observed (Figs. 2C, D) , and intervals between each myotome that expressed MyoD were found to have narrowed (Fig. 2E) . From the fifth to ninth somite, TeM was detectable at a higher level (Fig. 2D) . At the thoracic and lumber levels, Scx and TeM were expressed in the anterior and posterior borders of the sclerotome, beneath the myotome, in a double stripe pattern (Figs. 2C, D) . The ventrolateral expression of Scx was extended to the regions adjacent to the pectoral and abdominal muscles (arrows, Fig. 2C ), whereas TeM was only found to be expressed in the dorsomedial region at the thoracic region (asterisk, Fig. 2D ). It should be noted here that the dorsomedial-ventrolateral expression of TeM was observed at the cervical and lumber levels (Fig. 2D ). In the dorsal view, a similar v-shaped pattern of expression for TeM and Scx was observed and these patterns persisted along the axial skeleton until stage 31 (not shown). At the limb level, the expression of TeM was observed in the shoulder and pelvic girdles, and the proximal region of the wing and leg (Fig. 2D ). In the saggital sections at the thoracic level, overlapping expression of Scx and TeM was detected in the dorsal region (Figs. 2F, G) . Brent et al. previously reported that Scx positive domain is detectable just adjacent to the myotome at stage 20 (Brent et al., 2003) . Similarly, at stage 28, MyoD positive domain was detected between Scx or TeM positive domains (Figs. 2F-H) .
To determine the precise expression domains of TeM during axial development, we performed two-color whole mount in situ hybridization analysis using stage 25 chick embryos. MyoD expression was observed to span the full dorsomedialventrolateral length of the somites (Fig. 2I) . Moreover, TeM and MyoD act as markers for two adjacent but not overlapping cell populations at this developmental stage, as shown by a lateral view (Fig. 2I) and by a frontal section (Fig. 2J) . In contrast, overlapping expression domains were observed for TeM and Scx, indicating that TeM is also expressed in the syndetome (Fig. 2K ). Further analysis using transverse sections of hybridized embryos revealed that the TeM and Scx double positive cell populations are flanked by a single TeM positive cell population and Scx positive cell population (Figs. 2L, M) . By dissecting the hybridized embryos from the back in a frontal direction, we also confirmed that TeM single positive cell populations (purple) are present in the dorsomedial region (Fig.  2N) , followed by TeM/Scx double positive cell populations (Fig. 2O) . A Scx single positive cell population (orange) was then found to be present in the ventrolateral region (Fig. 2P) .
TeM is expressed in developing chick tendons
At stage 30, TeM positive domains were segmentally arranged along the vertebral column (Fig. 3A) . Scx was similarly expressed, but also detectable in the intercostal regions (Fig. 3B ). Both TeM and Scx were detectable in the regions between MyoD positive domains that were also segmentally arranged at this stage (Fig. 3C) . However, TeM positive domains started to fuse at stage 31 ( Fig. 3D ) and became cord-or sheet-like at stage 32 (Fig. 3E) . TeM marks both the developing axial tendons and the attachment sites of the tendons to the skeletal elements at stage 32 (Figs. 3E, H) . Strong signals were also observed in the dense connective tissues surrounding the pelvis (Fig. 3E) . In addition, a TeM positive domain was detected in the region along the scapula (arrowheads, Fig. 3E) . At the thoracic level, however, TeM was only detectable in the proximal regions of the ribs at this stage (arrows, Fig. 3E ). Scx was also observed to be a marker for the developing chick tendons, but its expression was found to be more associated with the muscular components (Figs. 3F, G) . The positive expression of Scx was clearly evident in the surrounding regions of the intercostal muscles (black arrows, Figs. 3F, G), the lateral iliotibial muscle (asterisk, Figs. 3F, G) and in the tendons connecting the scapula with the rhomboid and scapulohumeral muscle (red arrowheads, Fig. 3F ).
At stage 35, characteristic cord-or sheet-like structures of tendons can be visualized as expression domains of TeM (Fig.  4A) . Similarly, TeM and Scx are markers of the developing tendons in the wing at this stage (Figs. 4B, C) . TeM was also found to be expressed in nontendinous dense connective tissues, such as dermis, at stage 36 (arrowheads, Fig. 4D ), whereas Scx expression was not detectable at this point (Fig. 4E) . During stage 36, tenocytes synthesize type I collagen fibrils, but mature fibers of type I collagen, which stain dark blue via the azan method, were not observed (not shown). We then compared the expression domain of TeM with that of Scx in immature tendons. As shown in Figs. 4F and G, TeM is expressed in dense connective tissues located between the vertebrae, whereas Scx is not detectable in the corresponding regions. Scx expression was not detected in the intervertebral region at stages 29 and 41 (not shown). In contrast, in the trunk, Scx was clearly evident in the myotendinous junction of the intercostal muscles (Fig. 4H) , where TeM was undetectable at this stage (Fig. 4I) . At stage 41, mature fibers of dense connective tissues are formed in chick (Fig. 4K) and TeM can be detected in both the myotendinous and osteotendinous junctions during this time (Fig. 4J) . Thus, our analysis reveals the predominant expression of Scx in the myotendinous junction and of TeM in the chondrotendinous junction in immature tendons. 
2001).
TeM was also subsequently identified as one of a group of downregulated genes in a muscle atrophy model (Pisani et al., 2004) . To examine the precise expression domains of TeM in the developed musculoskeletal system in the chick, we performed a combination of in situ hybridization and immunostaining analysis. As shown in Fig. 4L , TeM was observed to be expressed in tendons that were located along the dorsal muscles and that were connecting muscle with the spinous processes at the cervical level. In the shoulder region, TeM was also shown to be expressed in tendons binding either the scapula or the vertebral arches with adjacent muscle masses, but not in muscle fibers (Fig. 4M) . TeM is also specifically expressed in the heel flexor and extensor tendons and is undetectable in hyaline cartilage that positively stains with anti-type II collagen antibodies (Fig. 4N ). In addition, TeM cannot be detected in muscle fibers but is evident in the myoseptum of the leg skeletal muscle, which can be positively stained with anti-myosin heavy chain antibodies (Fig. 4O) .
Azan staining of heel sections revealed that dense type I collagen fibers were distributed in tendons, dermis and cortex bone at stage 41 (Fig. 5A) . TeM was only detectable, however, in the dense connective tissues where thick bundles of collagen fibers can be found (Figs. 5B, D, E) . In contrast, expression of Col1a2 was detectable in both dense and loose connective tissues (Figs. 5C, D, F) . Maturation of tendons is associated with formation of the laminar configuration where oval and elongated tenocytes appear (Chuen et al., 2004) . Immature oval tenocytes derived from tendon progenitors rapidly proliferate and then mature to become elongated tenocytes. At a higher magnification, elongated tenocytes are aligned in parallel to thick mature collagen fibers to form the regular layer, whereas oval tenocytes are randomly distributed in the interlaminar spaces (Figs. 5G-I ). Although Col1a2 expression was detected in both oval and elongated tenocytes (Figs. 5G, K) , TeM expression was restricted to elongated tenocytes (Figs. 5H, J) . These data suggest that TeM is a marker of mature tenocytes in vivo.
TeM is a marker for tenocytes in vitro
Fibroblasts in tendons and ligaments in vivo are histologically distinct and can be characterized by longitudinal rows of winged cells, separated by an extracellular matrix. However, these cells are almost indistinguishable from fibroblasts in loose connective tissues in vitro, since their histological characteristics are lost in these conditions. To examine whether TeM is expressed in vitro, we isolated tenocytes from leg tendons at stage 41 chick embryos using both trypsin and collagenase 
domains (A-C). TeM is detectable in the center of backbone (A, arrowheads). Scx is detectable at the ventrolateral domain coincides with the incipient ribs and intercostals muscles (B, asterisk). At stage 31, adjacent TeM positive domains begin to fuse (D). (E-H) Skeletal preparations of the thoracolumbar region of a chick embryo at stage 32 are shown in comparison with dorsolateral views of stage 32 embryos hybridized with
TeM, MyoD and Scx riboprobes. Postulated regions of the scapula and pelvic girdle are depicted by a dotted line. TeM transcripts are detected in tendons and ligaments connecting the pelvic girdle with the surrounding muscle masses and bone rudiments, and the attachment sites of the connective tissues to the scapula (arrowheads) and the proximal region of ribs (arrows) (F). Scx is predominantly detected in the connective tissues on the outer margins of the muscle masses (arrows and asterisk in panel F) and in the tendons connecting the scapula with the surrounding muscle masses (arrowheads in panel F). Intercostal, leg and wing muscles are denoted by MyoD (G). shm, scapulohumeral muscle; icm, intercostal muscle; lim, lateral iliotibial muscle (M. iliotibialis lateralis); itm, iliotrochanteric msucle; rb, rib; s, scapula; f, femur; pl, pelvic girdle; T1, thoracic vertebra 1; L1, Lumber vertebra 1. digestion methods. The isolated tenocytes exhibited a fibroblastic morphology (Fig. 6A) and were found to express TeM, Col1a2, ChM-I, Col2a1 and Scx (Fig. 6C) , although the mRNA levels for TeM in these in vitro experiments are lower than the levels in tendons. We also isolated chondrocytes from the distal tibia with trypsin and collagenase, and these cells exhibited a polygonal morphology (Fig. 6B ) and expressed ChM-I, Col2a1 and Aggrecan (Fig. 6C, not shown) . The expression of TeM was not detectable in chondrocytes, whereas ChM-I was not evident in either tenocytes or in tendons (Fig. 6C) . Scx was detected in both tenocytes and chondrocytes (Fig. 6C) . Thus, TeM could be a promising marker for tenocytes in the monolayer culture.
Scx positively regulates the expression of TeM in tenocytes
To explore the functional roles of Scx in the regulation of tendon and cartilage cells, we overexpressed Scx in cultured tenocytes and chondrocytes using retroviruses. When expressed in chick embryonic fibroblasts, Flag tagged Scx displays a single band of ∼ 28 kDa, the expected size (Fig. 7A) (Cserjesi et In situ hybridization of TeM or Scx, followed by immunostaining, was performed on sections through embryos at stage 36. Muscle was detected with myosin heavy chain antibody (red brown), and cartilage with antitype II collagen antibody (yellow brown). In wing sections, TeM is detectable in the attachment sites of the tendon to the proximal end of the ulna (arrow in panel D) and the dermis (arrowheads in panel D), whereas Scx is undetectable in these regions (E). In the frontal sections of the vertebral column, TeM is evident in the intervertebral region (arrowheads in panel F), but Scx is not (G). In the thoracic level of the trunk, Scx is expressed in the connective tissue surrounding the intercostal muscles (arrows in H), whereas TeM is undetectable here at this stage (I). (J-K) At stage 41, in situ hybridization analysis of TeM (J) and Azan staining of collagen fibers (K) is performed on serial paraffin sections of the trunk. TeM is detectable in the region surrounding the intercostal muscles (arrows in panel J), associated with the dense fiber distribution observed as dark blue Azan staining (arrowheads in K). (L-O) In situ hybridization of TeM (purple) followed by immunostaining was performed on embryo sections at stage 35. Muscle was detected with myosin heavy chain antibody (red brown in panels L, M and O), and cartilage with anti-type II collagen antibody (yellow brown in panels L and M, or brown in N). In the frontal section of the backbone tissue, TeM is expressed in tendons along the dorsal muscles and in tendons connecting muscle with the spinous processes of the cervical vertebrae (L). In the shoulder region, TeM is detectable in the tendons connecting the scapula and vertebral arches with adjacent muscle masses (M). In the sagittal section of the leg, TeM transcripts are present in the developing heel flexor and extensor tendons (N). At higher magnification, TeM transcripts are evident in connective tissue encompassing muscle masses (O). u, ulna; fb, feather bud; vb, vertebral body; nc, notochord; rb, rib; icm, intercostals muscle; sp, spinous process; va, vertebral arch; s, scapula; ti, tibiotarsus. Scale bars, 100 μm.
al., 1995). The morphology of the tenocytes overexpressing Scx was similar to tenocytes overexpressing EGFP (Figs. 7B-D) . Although Scx overexpressing chondrocytes also exhibited a similar morphology to chondrocytes expressing EGFP (Figs. 7E-G), slight increases in alcian blue positive extracellular matrices were observed in day 6 chondrocyte cultures infected with RCAS-cScx (not shown).
We next examined the mRNA levels of various marker genes, including TeM and ChM-I, by Northern blotting. TeM was significantly upregulated in Scx overexpressing tenocytes but was downregulated together with TN by overexpression of Pax-1, a sclerotome marker that inhibits Scx expression in the syndetome (Fig. 7H) (Brent and Tabin, 2004) . In chondrocytes, Scx fails to induce TeM, but a slight upregulation of Agg and ChM-I could be detected (Fig.  7H) . We then misexpressed Myogenin as other type of b-HLH type transcription factor in tenocytes. Northern blot analysis revealed that TeM and Scx expression was significantly downregulated in tenocytes that misexpressed Myogenin to form myotoubes in the presence of 0.5% FBS (Fig. 7I) . This is consistent with our observation that TeM was not expressed in myogenic or muscle cells (Figs. 2, 3, 4O ). In addition, the data suggested that TeM upregulation by Scx was not simply attributed to a genial b-HLH activity, but specific to Scx.
We also tested Scx function in the developing hindlimb, taking advantage of in ovo electroporation technology. We electroporated retroviral vectors directly into the hindlimbs of stage 16-17 embryos. Unlike the injection of infectious retrovirus particles, electroporated retroviral DNA gradually propagates in the hindlimb and env expression was detectable in the right leg of stage 28 embryos by whole mount in situ hybridization (Fig. 8A) . Since obvious morphological phenotypes were not evident, we analyzed the expression of TeM in stage 30, 33 and 35 embryos by whole mount in situ hybridization. We did not detect any significant changes in the right leg, that was misexpressing Scx, until stage 30 (Fig.  8B) . At stage 33, the propagation of RCAS-Scx throughout the leg was observed (Fig. 8C) and then the significant upregulation of TeM was detectable in the right leg tendons of 7/20 embryos, when compared with the contralateral left leg (Fig. 8D) . At stage 35, the upregulation of TeM was detectable in 12/20 embryos (Fig. 8E) . The effect of Scx overexpression was not site-specific, consistent with our in vitro data that tenocytes isolated from various leg tendons were equally responsive to Scx. In situ hybridization analysis revealed that TeM expression in the infected or the contralateral legs was only evident in developing tendons and other dense connective tissues (Figs.  8F, I ), even though the retroviral expression of Scx was observable in the entire leg, including muscle and loose connective tissue (not shown). Consistent with our in vitro analyses, the expression of TeM was not found outside the endogenous expression domains (Figs. 8F-I) . Upregulation of TeM upon Scx infection was also confirmed by Northern blot analysis (Fig. 8J) .
Discussion
During chick axial tendon development, Scx is first induced at stage 18 and its expression intensifies during somite maturation (Brent et al., 2003) . Moreover, up until stage 23, Scx expression in the syndetome extends to the tail region ( Fig. 2A) , whereas TeM is only expressed in the anterior eight somites (Fig. 2B) . Since segmentation occurs from the cranial to the tail region along the anteroposteior axis, the later and more restricted expression profile of TeM may reflect the ongoing formation of tendon primordia at the upper cervical region.
Indeed, at stage 28, the expression of TeM becomes more regionally characteristic than Scx (Figs. 2C, D) . As chick vertebrae display distinct morphological features at different levels, TeM was also expressed differently in the cervical, thoracic and lumbosarcal regions.
In the appendicular region, tendon primordia divide into individual tendons that interact with developing muscles and skeletal elements (Kardon, 1998) . In the axial region, each tendon primordium should be reorganized to form individual tendons due to the polymerization of epaxial muscles (Christ et al., 2000) . As the superficial part of the segmentally arranged epaxial muscle anlagen fuse to give rise to segment-overbridging muscles, already existing tendons lose their connection with the muscle and disappear. Monitoring TeM and Scx expression, we found that the positive domains of these genes became cord-or sheet-like at around stage 32.
At the initial stages of tendon development, the expression of TeM and Scx does not completely overlap. Indeed, simultaneous detection of Scx and TeM by two color in situ hybridization of the cervical regions in a stage 25 embryo reveals three different populations along the dorsoventral axis (Fig. 2M) . . Grafting experiments using chick-quail chimera showed that axial tendon cells are of sclerotomal origin (Brent et al., 2003) . However, recent analysis of Ets transcription factors that restrict Scx expression in the somites revealed that Scx was also expressed in small subsets of dermomyotome (Brent and Tabin, 2004) . TeM single positive populations in the dorsal region may indicate an additional contribution to tendon formation by dermomyotome cells. However, we could not exclude the possibility that cells previously expressing Scx in the syndetome migrate to the dorsal region and downregulate Scx due to the influence of surrounding tissue, thus allowing cells to express only TeM. Alternatively, TeM single positive cell populations may represent the prospective dermis arising from dermomyotome, since TeM is also expressed in nontendinous tissues such as dermis and ligaments (Figs. 4D, F) .
Tenocytes lie in longitudinal rows and mature to become very elongated, being 80-300 μm in diameter, and have long and thin cellular processes by which close contact between adjacent cells and extracellular matrices is maintained (McNeilly et al., 1996) . Due to their unique morphological features, tenocytes are easily distinct from other fibroblasts in loose connective tissues, such as hypodermis and submucosal tissue, in vivo. However, once these cells are isolated from tissues and cultured in vitro, their cellular morphology and longitudinal alignments are lost and they become indistinguishable from fibroblasts derived from loose connective tissues. The current lack of a phenotypic marker for tenocytes in vitro also makes it difficult to establish a culture system for their induction from stem cells. Scx is a good marker of the tendon cell lineage in vivo, but seems inappropriate to use in vitro due to its expression in skeletal lineage cells. Scx expression is detectable in various cell lines derived from the skeletal lineage, such as MC3T3-E1, ROS17/2.8 and ATDC5 (Liu et al., 1997 ) (unpublished data), and cultured chondrocytes (Fig. 6C) . In contrast, TeM is not expressed in these skeletal cell lines (unpublished data), but is only detectable in tenocytes in vitro (Fig. 6C) . The combination of Scx as an early marker and TeM as a late marker should now enable clarification of the molecular mechanisms underlying tenocyte differentiation and tendon regeneration.
Dense connective tissues, including tendons and ligaments, are characterized by regularly oriented type I collagen fibers (Benjamin and Ralphs, 1997; Kannus, 2000) . Although tenocytes in monolayer cultures have the ability to synthesize large amounts of type I collagen (Fig. 7H) , these cells lose their characteristic elongated morphology and their fibrils are randomly distributed (Fig. 6A) . Northern blots also reveal that TeM transcripts in cultured tenocytes are at lower levels than in tendons (Fig. 6C) . In contrast, the mRNA levels for Scx in vitro are similar to those in vivo (Fig. 6C ). Higher levels of TeM were detectable only in dense regular collagen fibers, stained by azan (Figs. 5A, B, D, E) , suggesting a close correlation between TeM expression and the regular alignment of collagen fibers. Moreover, TeM expression domain is highly restricted to elongated tenocytes in mature tendons (Figs. 5G, H, J) . Mice lacking TeM display uneven and rough fibril surfaces on their tendons (Docheva et al., 2005) , further indicating that TeM is involved in the formation of organized tendon structures, which reciprocally affect TeM levels.
A number of basic helix-loop-helix type transcription factors are involved in cellular differentiation (Jones, 2004) . Ectopic expression of the myogenic basic helix-loop-helix transcription factors transdifferentiates some fibroblasts into myoblasts, which can differentiate into skeletal muscle when cultured in low mitogen medium (Tapscott et al., 1988) . To explore the effects of Scx overexpression in nontendinous cells, we expressed RCAS-cScx in chondrocytes isolated from distal tibiae, which slightly upregulated aggrecan mRNA levels ( Fig.  7H ) and alcian blue positive extracellular matrices (not shown). However, the induction of TeM in chondrocytes overexpressing Scx was not observed (Fig. 7H) . In contrast, the overexpression of Scx in tenocytes significantly upregulates TeM mRNA, despite the induction of the dominant negative factors Id2 and Id3 (not shown). Col1a2 and TN expression levels and the cellular morphology of tenocytes were unaffected by the overexpression of Scx (Figs. 7D, H) . Conversely, the overexpression of Pax1 results in downregulation of TeM and TN (Fig. 7H) , suggesting that Pax1 downregulates phenotypic markers in the later stages of tendon development. Although both tenocytes and chondrocytes are derived from common Although the expression of TeM was detectable in the leg tendons and other dense connective tissues, the signal was never detected ectopically in cartilage, muscle or loose connective tissues (F, H). Positive signals are undetectable on the section hybridized with sense TeM riboprobe (G). (I) Endogenous expression of TeM is detectable in leg tendons and other dense connective tissues of the contralateral left leg. me, tarsometatarsus; ti, tibiotarsus. Scale bar, 100 μm. (J) RCAS-cScx was electroporated with RCAS-EGFP into the hindlimb. cScx was subcloned into RCASBP(A), whereas EGFP was subcloned into RCASBP(B). Total RNA was extracted from the EGFP positive region and the equivalent region of the contralateral leg, respectively. Total RNA (15 μg) extracted from the contralateral left leg (lane 1) or the RCAS-cScx/RCAS-EGFP infected right leg (lane 2) was loaded and hybridized with TeM or env cDNA probes. Upregulation of TeM is detectable in the RCAS-cScx/RCAS-EGFP infected leg (lane 2). Equal loading was verified with ethidium bromide.
progenitors in the sclerotome and lateral plate mesoderm, the positive regulation of TeM expression by Scx is dependent on the tendon cell lineage.
Misexpression of Scx in the hindlimb fails to induce extopic formation of the tendinous primordia or ectopic tendons (Fig.  8) . These findings are in good agreement with a previous study showing that the expansion of Scx expressing regions by noggin did not induce tendinous tissue formation (Schweitzer et al., 2001) . Although the basic patterns of tendon primordia are unaffected by broad misexpression of Scx in the developing leg, we found significant upregulation of TeM mRNA in tendons overexpressing Scx at stage 33 and later (Figs. 8D, E) . Upregulation of TeM expression was detected in whole legs overexpressing Scx by Northern blot analysis (Fig. 8J) . In nontendinous tissues, including muscle and cartilage, Scx fails to induce TeM expression, consistent with our in vitro data (Figs. 7H, 8F ). The altered responsiveness to Scx overexpression in mature tendons may suggest that the competence of tenocytes in leg tendons is significantly altered at stage 33. Considering later onset of TeM induction than that of Scx along the course of tendon development, it is obvious that additional factors are required for further differentiation of Scx expressing tendon progenitors into TeM expressing tenocytes. In addition, TeM expression was not overlapped with Scx expression in dermis and the intervertebral region, suggesting that the expression of TeM was regulated by other factors independently from Scx.
Scx binds the E-box consensus sequence (CANNTG) as a heterodimer with E12 (Cserjesi et al., 1995) and these motifs are found throughout the chick TeM genes (now shown). However, it is still uncertain whether TeM is a direct downstream target of Scx. In addition, the expression of TeM in the Scx negative region suggests that other factors are involved in tendon development, independently of Scx. To address these questions, the cis-acting element driving the specific expression of TeM in tenocytes and the trans-acting factors binding these regions should be identified. Such studies are currently underway.
